Physicians identified key improvements for adrenaline auto-injectors, including longer shelf life and easier use, improving anaphylaxis care. Learn more.
The FDA approved the first nalmefene hydrochloride auto-injector (Zurnai) for use as an emergency treatment for opioid overdose in adults and children 12 years of age and older, the agency announced ...
Emergent BioSolutions ($EBS) has launched a military-grade intramuscular auto-injector device for self-administered antidotes or other chemical threat treatments. For ...
WALTHAM, Mass., June 26, 2017 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced that the U.S. Food and Drug Administration (FDA) accepted the supplemental new drug ...
Anaphylaxis is a serious, potentially life-threatening allergic reaction that can affect several organ systems in the body and may threaten breathing and blood circulation. The most common causes of ...
The privately-held, Richmond, Virginia-based kaléo Pharma (formerly Intelliject) today received FDA approval for Evzio®, an automatic injector of the opioid overdose antidote, naloxone, specifically ...
Study showed 94% of patients preferred new device over existing Avonex prefilled syringe. The European regulatory authorities approved Biogen Idec’s single-use intramuscular autoinjector, Avonex PEN, ...
The European Medicines Agency (EMA) has recommended several measures to better ensure appropriate patient and carer use of adrenaline auto-injectors for severe allergic reactions. The move is prompted ...
San Diego, California — It's still early days, but brand-new formulations of rescue benzodiazepine could be in store for patients who have acute repetitive seizures (ARS). Promising phase 3 trial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results